Evaluation of New Specifications (38mm) of FirehawkTM in the Treatment of Coronary Heart Disease

NCT02688842 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

38

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Heart Disease

Interventions

DEVICE: Rapamycin target-eluting coronary stent systems (38mm)

Sponsor

Shanghai MicroPort Medical (Group) Co., Ltd.